These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1322481)

  • 81. Structural characterization of melatonin as an inhibitor of the Wnt deacylase Notum.
    Zhao Y; Ren J; Hillier J; Jones M; Lu W; Jones EY
    J Pineal Res; 2020 Mar; 68(2):e12630. PubMed ID: 31876313
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A novel method of preparing amine-modifying C-4' oxidized nucleotide.
    Aso M; Ryuo K; Kondo M; Suemune H
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1384-6. PubMed ID: 10993247
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Mass spectrometric and nuclear magnetic resonance confirmation of a 3,3-spirocyclic indole derivative formed from melatonin and related acyl tryptamines.
    Blau K; King GS; Sandler M
    Biomed Mass Spectrom; 1977 Aug; 4(4):232-6. PubMed ID: 912022
    [TBL] [Abstract][Full Text] [Related]  

  • 84. New spectrofluorimetric methods for determination of melatonin in the presence of N-{2-[1-({3-[2-(acetylamino)ethyl]-5-methoxy-1H-indol-2-yl}methyl)-5-methoxy-1H-indol-3-yl]- ethyl}acetamide: a contaminant in commercial melatonin preparations.
    Darwish HW; Attia MI
    Chem Cent J; 2012 May; 6(1):36. PubMed ID: 22551394
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Erratum to: New spectrofluorimetric methods for determination of melatonin in the presence of
    Darwish HW; Attia MI; Zlotos DP
    Chem Cent J; 2016; 10():57. PubMed ID: 28316642
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Synthesis of New 2,3-Dihydroindole Derivatives and Evaluation of Their Melatonin Receptor Binding Affinity.
    Volkova MS; Efremov AM; Bezsonova EN; Tsymliakov MD; Maksutova AI; Salykina MA; Sosonyuk SE; Shevtsova EF; Lozinskaya NA
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364290
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Bromonium ion-promoted glycosidic bond formation and simultaneous bromination of an activated aryl aglycon.
    Qin ZH; Li H; Cai MS; Li ZJ
    Carbohydr Res; 2002 Jan; 337(1):31-6. PubMed ID: 11755909
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Quantum mechanics insights into melatonin and analogs binding to melatonin MT
    de Lima Menezes G; Sales Bezerra K; Nobre Oliveira JI; Fontenele Araújo J; Soares Galvão D; Alves da Silva R; Vogel Saivish M; Laino Fulco U
    Sci Rep; 2024 May; 14(1):10922. PubMed ID: 38740789
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Analgesic, anxiolytic and anaesthetic effects of melatonin: new potential uses in pediatrics.
    Marseglia L; D'Angelo G; Manti S; Aversa S; Arrigo T; Reiter RJ; Gitto E
    Int J Mol Sci; 2015 Jan; 16(1):1209-20. PubMed ID: 25569095
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Melatonin.
    Pévet P
    Dialogues Clin Neurosci; 2002 Mar; 4(1):57-72. PubMed ID: 22034091
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Melatonin receptor agonists: new options for insomnia and depression treatment.
    Spadoni G; Bedini A; Rivara S; Mor M
    CNS Neurosci Ther; 2011 Dec; 17(6):733-41. PubMed ID: 21554566
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists.
    Nonno R; Pannacci M; Lucini V; Angeloni D; Fraschini F; Stankov BM
    Br J Pharmacol; 1999 Jul; 127(5):1288-94. PubMed ID: 10455277
    [TBL] [Abstract][Full Text] [Related]  

  • 93. An attempt to correlate brain areas containing melatonin-binding sites with rhythmic functions: a study in five hibernator species.
    Masson-Pévet M; George D; Kalsbeek A; Saboureau M; Lakhdar-Ghazal N; Pévet P
    Cell Tissue Res; 1994 Oct; 278(1):97-106. PubMed ID: 7954706
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Iodinated melatonin: preparation and characterization of the molecular structure by mass and 1H NMR spectroscopy.
    Vakkuri O; Lämsä E; Rahkamaa E; Ruotsalainen H; Leppäluoto J
    Anal Biochem; 1984 Nov; 142(2):284-9. PubMed ID: 6549370
    [TBL] [Abstract][Full Text] [Related]  

  • 95. 2-Substituted 5-methoxy-N-acyltryptamines: synthesis, binding affinity for the melatonin receptor, and evaluation of the biological activity.
    Spadoni G; Stankov B; Duranti A; Biella G; Lucini V; Salvatori A; Fraschini F
    J Med Chem; 1993 Dec; 36(25):4069-74. PubMed ID: 8258829
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pharmacology and function of melatonin receptors.
    Dubocovich ML
    FASEB J; 1988 Sep; 2(12):2765-73. PubMed ID: 2842214
    [TBL] [Abstract][Full Text] [Related]  

  • 97. 2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist.
    Duranti E; Stankov B; Spadoni G; Duranti A; Lucini V; Capsoni S; Biella G; Fraschini F
    Life Sci; 1992; 51(7):479-85. PubMed ID: 1322481
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Melatonin signal transduction and mechanism of action in the central nervous system: using the rabbit cortex as a model.
    Stankov B; Biella G; Panara C; Lucini V; Capsoni S; Fauteck J; Cozzi B; Fraschini F
    Endocrinology; 1992 Apr; 130(4):2152-9. PubMed ID: 1312448
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.